3 research outputs found
Semisynthesis of Libiguin A and Its Analogues by Trans-Lactonization of Phragmalin
Libiguins are limonoids with highly
potent sexual activity enhancing
effects, originally isolated from the Madagascarian Meliaceae species Neobeguea mahafalensis, where they exist in only
minute quantities. Their low natural abundance has hampered mapping
of their biological effects. Here we describe an approach to the semisynthesis
of libiguin A and its close analogues <b>1</b>–<b>3</b> starting from phragmalin, which is a limonoid present in
high amounts in a commercially cultivated Meliaceae species, Chukrasia tabularis, allowing the preparation of
libiguins in appreciable quantities
Targeting Carnitine Biosynthesis: Discovery of New Inhibitors against γ‑Butyrobetaine Hydroxylase
γ-Butyrobetaine
hydroxylase (BBOX) catalyzes the conversion
of gamma butyrobetaine (GBB) to l-carnitine, which is involved
in the generation of metabolic energy from long-chain fatty acids.
BBOX inhibitor 3-(1,1,1-trimethylhydrazin-1-ium-2-yl)Âpropanoate (mildronate),
which is an approved, clinically used cardioprotective drug, is a
relatively poor BBOX inhibitor and requires high daily doses. In this
paper we describe the design, synthesis, and properties of 51 compounds,
which include both GBB and mildronate analogues. We have discovered
novel BBOX inhibitors with improved IC<sub>50</sub> values; the best
examples are in the nanomolar range and about 2 orders of magnitude
better when compared to mildronate. For six inhibitors, crystal structures
in complex with BBOX have been solved to explain their activities
and pave the way for further inhibitor design